M&T Bank’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,857
Closed -$214K 1680
2022
Q1
$214K Sell
4,857
-77
-2% -$3.31K ﹤0.01% 1358
2021
Q4
$215K Buy
+4,934
New +$193K ﹤0.01% 1421
2021
Q3
Sell
-5,206
Closed -$220K 1609
2021
Q2
$220K Buy
+5,206
New +$203K ﹤0.01% 1421
2018
Q3
Sell
-10,224
Closed -$170K 1603
2018
Q2
$170K Buy
10,224
+54
+0.5% +$874 ﹤0.01% 1449
2018
Q1
$158K Buy
+10,170
New +$181K ﹤0.01% 1459
2015
Q2
Sell
-7,404
Closed -$251K 2168
2015
Q1
$251K Sell
7,404
-528
-7% -$18.4K ﹤0.01% 1596
2014
Q4
$277K Sell
7,932
-3,249
-29% -$109K ﹤0.01% 1541
2014
Q3
$366K Buy
+11,181
New +$380K ﹤0.01% 1425

Other funds holding ACH

M&T Bank's ACH Position: Q2 2022 in Review

M&T Bank sold out of Accendra Health (ACH) in Q2 2022, closing a stake of 4,857 shares — an estimated $214K sold.

M&T Bank first reported a position in ACH in Q3 2014 and held it in 8 quarters. The position peaked at $366K in Q3 2014. 251 funds tracked by Wall St. Rank hold ACH as of Q2 2022.

  • M&T Bank reported no remaining Accendra Health position as of Q2 2022 after selling out during the quarter.
  • M&T Bank sold 4,857 Accendra Health shares in Q2 2022, an estimated $214K.
  • M&T Bank first reported a position in Accendra Health in Q3 2014 and held it in 8 quarters.
  • M&T Bank's Accendra Health position peaked at $366K in Q3 2014.
  • 251 funds tracked by Wall St. Rank held Accendra Health as of Q2 2022.

Based on M&T Bank's 13F filing for Q2 2022, filed 5 Aug 2022.